UBS reiterates Under Armour stock rating ahead of earnings By Investing.com

UBS reiterated a Buy on Under Armour with an $11 price target, implying upside from the $6.22 share price ahead of earnings on May 12. The firm expects a 2-cent Q4 EPS beat and fiscal 2027 EPS guidance of $0.25 to $0.30, though it flagged risks from elevated oil prices, macro uncertainty, and a second-half weighted outlook. Sentiment remains very bearish, but UBS said the stock should clear a low bar; implied earnings move is about 9.3% versus an 11.0% historical average.

Analysis

The setup is less about one quarter and more about whether UAA can convert a low bar into a sustained sentiment reset. When positioning is this one-sided, even a modest guide can squeeze shorts and systematic underweights because the stock’s beta makes it a high-elasticity response to narrative change. The key second-order effect is that a cleaner outlook could re-open access to promotional shelf space and wholesale conversations that have likely been constrained by prior skepticism, improving sell-through without needing heroic demand assumptions.

The bigger risk is that macro input costs and consumer elasticity collide right when management needs credibility. If guidance is pushed into the back half, the market will likely discount it heavily because execution risk compounds when visibility is low and the base is depressed. That matters more for this name than for peers: a guide that looks merely “possible” rather than “achievable” can keep the multiple trapped even if the quarter itself beats.

CROX is the cleaner relative beneficiary from the discretionary footwear lens because social-commerce traction implies product-market fit and better customer acquisition efficiency, which is far harder to manufacture than a one-off earnings beat. If UAA reports well, some of the event-driven capital likely rotates within battered consumer discretionary laggards, but CROX should capture a larger share of that flow given its stronger incremental demand signal. The contrarian read is that the market may be underestimating how much a single credible guide can matter for UAA’s terminal multiple — but only if management avoids overpromising on the outer-year ramp.

Key Decisions for Investors

• Long UAA into earnings as a tactical event trade; size for a ±9-10% move and cover/trim into the print if shares gap 8%+ higher, since the reward is mostly sentiment compression rather than a durable rerating.
• Buy UAA May/June call spreads rather than outright stock to express upside from a beat-plus-clean-guide while limiting downside if management punts on fiscal 2027 visibility.
• If long consumer discretionary beta, rotate a portion from UAA into CROX on any UAA post-earnings strength; CROX has the cleaner second-order demand signal and better odds of trend continuation over 1-3 months.
• For hedged portfolios, consider a UAA/CROX pair: long CROX vs short UAA after the earnings event if UAA rallies on guide relief, since CROX’s channel momentum should command the higher multiple.
• If UAA gaps down on weak guidance, wait 1-2 sessions before buying; the better entry is likely after the first flush, when implied volatility collapses and the market can distinguish execution miss from structural deterioration.